Norges Bank’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Norges Bank’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-42,835	Closed	-$1.81M	–	2002
2024 Q1	$1.81M	Hold	42,835	–	–	﹤0.01%	1746
2023 Q4	$1.79M	Sell	42,835 -7,429	-15%	-$274K	﹤0.01%	1803
2023 Q3	$1.9M	Sell	50,264 -10,526	-17%	-$395K	﹤0.01%	1840
2023 Q2	$2.31M	Hold	60,790	–	–	﹤0.01%	1855
2023 Q1	$1.48M	Hold	60,790	–	–	﹤0.01%	1958
2022 Q4	$1.77M	Hold	60,790	–	–	﹤0.01%	1985
2022 Q3	$1.82M	Hold	60,790	–	–	﹤0.01%	1924
2022 Q2	$2.2M	Hold	60,790	–	–	﹤0.01%	1890
2022 Q1	$2.63M	Hold	60,790	–	–	﹤0.01%	1953
2021 Q4	$3.05M	Hold	60,790	–	–	﹤0.01%	1987
2021 Q3	$3.87M	Hold	60,790	–	–	﹤0.01%	1961
2021 Q2	$4.37M	Sell	60,790 -14,000	-19%	-$1.03M	﹤0.01%	1924
2021 Q1	$5.52M	Sell	74,790 -43,957	-37%	-$3.34M	﹤0.01%	1893
2020 Q4	$8.72M	Sell	118,747 -9,413	-7%	-$605K	﹤0.01%	1791
2020 Q3	$7.03M	Sell	128,160 -33,587	-21%	-$2.09M	﹤0.01%	1809
2020 Q2	$10.8M	Sell	161,747 -24,681	-13%	-$1.66M	﹤0.01%	1698
2020 Q1	$11.4M	Sell	186,428 -4,048	-2%	-$300K	﹤0.01%	1557
2019 Q4	$16.7M	Sell	190,476 -10,485	-5%	-$884K	﹤0.01%	1610
2019 Q3	$15.2M	Sell	200,961 -23,763	-11%	-$1.93M	﹤0.01%	1618
2019 Q2	$19.2M	Sell	224,724 -21,325	-9%	-$2.11M	0.01%	1530
2019 Q1	$26.6M	Hold	246,049	–	–	0.01%	1303
2018 Q4	$20.8M	Hold	246,049	–	–	0.01%	1374
2018 Q3	$24.2M	Hold	246,049	–	–	0.01%	1420
2018 Q2	$28.5M	Hold	246,049	–	–	0.01%	1268
2018 Q1	$24.3M	Hold	246,049	–	–	0.01%	1305
2017 Q4	$25.8M	Buy	246,049 +32,725	+15%	+$3.6M	0.01%	1291
2017 Q3	$24M	Hold	213,324	–	–	0.01%	1317
2017 Q2	$23.9M	Sell	213,324 -30,807	-13%	-$3.48M	0.01%	1280
2017 Q1	$28.5M	Buy	244,131 +12,712	+5%	+$1.41M	0.01%	1135
2016 Q4	$24.4M	Buy	231,419 +19,694	+9%	+$2.06M	0.01%	1186
2016 Q3	$22.3M	Buy	211,725 +8,461	+4%	+$1.12M	0.01%	1163
2016 Q2	$29.6M	Buy	203,264 +9,755	+5%	+$1.38M	0.01%	946
2016 Q1	$27.7M	Hold	193,509	–	–	0.01%	952
2015 Q4	$29.9M	Buy	193,509 +139,662	+259%	+$20.4M	0.01%	889
2015 Q3	$7.7M	Buy	+53,847	New	+$7.53M	﹤0.01%	1707

Other funds holding TARO

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

AIIMS

Analyst IMS Investment Management Services Tel-Aviv, Israel $3.3B AUM 20.27% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return

GCM

Gladius Capital Management Chicago, Illinois $2.24B AUM 23.45% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Norges Bank's TARO Position: Q2 2024 in Review

Norges Bank sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 42,835 shares — an estimated $1.81M sold.

Norges Bank first reported a position in TARO in Q3 2015 and held it in 35 quarters. The position peaked at $29.9M in Q4 2015. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

Norges Bank reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
Norges Bank sold 42,835 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $1.81M.
Norges Bank first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2015 and held it in 35 quarters.
Norges Bank's Taro Pharmaceutical Industries Ltd. position peaked at $29.9M in Q4 2015.
16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Norges Bank's 13F filing for Q2 2024, filed 14 Aug 2024.